EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Distinct transcription factor interactions drive HOXB13 activity in different stages of prostate cancer

Betul Ersoy-Fazlioglu iD, Shreyas Lingadahalli, Umut Berkay Altintas iD, Ahmet Cingoz iD, Emirhan Tekoglu iD, Ivan Pak Lok Yu, Meric Dikbas, Olka Missaghimamaghani, Kerim Yavuz iD, Hans Adomat iD, Ibrahim Kulac iD, Tunc Morova und 11 weitere

Proceedings of the National Academy of Sciences · 09.12.2025 · 122 (49)

DOI: 10.1073/pnas.2500327122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 04.12.2025. Verfasst von Betul Ersoy-Fazlioglu und 22 weiteren Autor:innen. Beteiligte Einrichtung: Koç University Research Center for Translational Medicine, Istanbul 34450, Türkiye. Hauptthemen laut MEDLINE: Homeodomain Proteins, Prostatic Neoplasms, Transcription Factors. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, CIHR | Canadian Institutes of Health Research - Antimicrobial Resistance Research Initiative (AMR), Prostate Cancer Fight Foundation (PCFF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HOXB13 is a lineage-specific transcription factor that plays a critical role in initiation and progression of prostate cancer (PCa). While most research has focused on the role of HOXB13 on androgen receptor (AR) activity, here we demonstrate that HOXB13 is frequently expressed in AR-negative tumors and is essential for the proliferation of both AR-positive and -negative PCa models. Strikingly, HOXB13 is remarkably selective and has almost no effect on nonprostatic tissues. Despite this common essentiality in PCa, HOXB13 activity is markedly different in AR-negative stem cell–like tumors, where interactions with the AP-1 change the HOXB13 cistrome and interactome. Yet despite these distinct activities, HOXB13 activity is commonly mediated by SMARCD2, a member of the mSWI/SNF chromatin remodeling complex. The HOXB13/SMARCD2 interaction alters chromatin accessibility at HOXB13-binding sites, causing increased proliferation in AR-negative PCa. Overall, this work demonstrates a distinct mechanism of action for HOXB13 and highlights its critical role in AR-negative castration-resistant PCa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Homeodomain ProteinsProstatic NeoplasmsTranscription FactorsMaleHumansReceptors, AndrogenCell ProliferationGene Expression Regulation, NeoplasticCell Line, TumorAnimalsMice

Stichwörter der Autor:innen

HOXB13androgen receptormSWI/SNFprostate cancer

Substanzen

Homeodomain ProteinsHOXB13 protein, humanReceptors, AndrogenTranscription FactorsAR protein, human

Autor:innen und Institutionen

  • Koç University Research Center for Translational Medicine, Istanbul 34450, Türkiye.
  • Department of Medical Pharmacology, School of Medicine, Koç University, Istanbul 34450, Türkiye.
  • Vancouver Prostate Centre, Vancouver, BC V6H 3Z6, Canada.
  • Department of Urologic Science, University of British Columbia, Vancouver, BC V5Z 1M9, Canada.
  • Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215.
  • Division of Oncogenomics, Oncode Institute, Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands.

ORCID-Profile: Betul Ersoy-Fazlioglu, Umut Berkay Altintas, Ahmet Cingoz, Emirhan Tekoglu, Kerim Yavuz, Hans Adomat, Ibrahim Kulac, Wilbert Zwart, Tugba Bagci-Onder, Nathan A Lack

Förderung

  • NCI NIH HHS
  • CIHR | Canadian Institutes of Health Research - Antimicrobial Resistance Research Initiative (AMR)
  • Prostate Cancer Fight Foundation (PCFF)
  • TUBITAK | Ulusal Metroloji Enstitüsü, Türkiye Bilimsel ve Teknolojik Araştirma Kurumu (TÜBİTAK UME)
  • North Spore

Zitieren

APA

Ersoy-Fazlioglu, B., Lingadahalli, S., Altintas, U. B., Cingoz, A., Tekoglu, E., Lok Yu, I. P., Dikbas, M., Missaghimamaghani, O., Yavuz, K., Adomat, H., Kulac, I., Morova, T., Xiao, K., Gleave, M., Fazli, L., Cejas, P., Cherkasov, A., Zwart, W., Haffner, M. C., …, & Lack, N. A. (2025). Distinct transcription factor interactions drive HOXB13 activity in different stages of prostate cancer. Proceedings of the National Academy of Sciences, 122(49). https://doi.org/10.1073/pnas.2500327122

Vancouver

Ersoy-Fazlioglu B, Lingadahalli S, Altintas UB, Cingoz A, Tekoglu E, Lok Yu IP, et al. Distinct transcription factor interactions drive HOXB13 activity in different stages of prostate cancer. Proceedings of the National Academy of Sciences. 2025;122(49). doi:10.1073/pnas.2500327122

BibTeX
@article{ErsoyFazlioglu2025,
  author = {Ersoy-Fazlioglu, Betul and Lingadahalli, Shreyas and Altintas, Umut Berkay and Cingoz, Ahmet and Tekoglu, Emirhan and Lok Yu, Ivan Pak and Dikbas, Meric and Missaghimamaghani, Olka and Yavuz, Kerim and Adomat, Hans and Kulac, Ibrahim and Morova, Tunc and Xiao, Kevin and Gleave, Martin and Fazli, Ladan and Cejas, Paloma and Cherkasov, Artem and Zwart, Wilbert and Haffner, Michael Christoph and Long, Henry W and Collins, Colin and Bagci-Onder, Tugba and Lack, Nathan A},
  title = {Distinct transcription factor interactions drive HOXB13 activity in different stages of prostate cancer},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  volume = {122},
  number = {49},
  doi = {10.1073/pnas.2500327122}
}
Kostenlos starten →